PHRMA CPCDC initiative on predictive models of human pharmacokinetics, part 5: Prediction of plasma concentration–time profiles in human by using the physiologically‐based pharmacokinetic modeling approach-Reference-Cited by-同舟云学术

PHRMA CPCDC initiative on predictive models of human pharmacokinetics, part 5: Prediction of plasma concentration–time profiles in human by using the physiologically‐based pharmacokinetic modeling approach

Published:2011-10 Issue:10 Volume:100 Page:4127-4157
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Poulin Patrick,Jones Rhys D.O.,Jones Hannah M.,Gibson Christopher R.,Rowland Malcolm,Chien Jenny Y.,Ring Barbara J.,Adkison Kimberly K.,Ku M. Sherry,He Handan,Vuppugalla Ragini,Marathe Punit,Fischer Volker,Dutta Sandeep,Sinha Vikash K.,Björnsson Thorir,Lavé Thierry,Yates James W.T.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference50 articles.

1. PhRMA CPCDC initiative on predictive models of human pharmacokinetics. 1. Goals, properties of the PhRMA dataset and comparison with literature datasets;Poulin;J Pharm Sci,2011

2. PhRMA CPCDC initiative on predictive models of human pharmacokinetics. 2. Comparative assessment of prediction methods of human volume of distribution;Jones;J Pharm Sci,2011

3. PhRMA CPCDC initiative on predictive models of human pharmacokinetics. 3. Comparative assessment of prediction methods of human clearance;Ring;J Pharm Sci,2011

4. Prediction of human pharmacokinetics from preclinical information: Comparative accuracy of quantitative prediction approaches;Hosea;J Clin Pharmacol,2009

5. PhRMA CPCDC initiative on predictive models of human pharmacokinetics. 4. Prediction of plasma concentration–time profiles in human from in vivo preclinical data by using the Wajima approach;Vuppugalla;J Pharm Sci,2011

Cited by 154 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transforming the Discovery of Targeted Protein Degraders: The Translational Power of Predictive PK/PD Modeling;Clinical Pharmacology & Therapeutics;2024-05-06

2. Using molecularly dissolved drug concentrations in PBBMs improves the prediction of oral absorption from supersaturating formulations;European Journal of Pharmaceutical Sciences;2024-03

3. Evaluation of commonin vitroassays for the prediction of oral bioavailability and hepatic metabolic clearance in humans;2024-02-28

4. EANM guidance document: dosimetry for first-in-human studies and early phase clinical trials;European Journal of Nuclear Medicine and Molecular Imaging;2024-02-17

5. Building a Predictive PBPK Model for Human OATP Substrates: a Strategic Framework for Early Evaluation of Clinical Pharmacokinetic Variations Using Pitavastatin as an Example;The AAPS Journal;2024-01-05